PMID- 32705451 OWN - NLM STAT- MEDLINE DCOM- 20210818 LR - 20210818 IS - 1557-1920 (Electronic) IS - 1557-1912 (Linking) VI - 23 IP - 3 DP - 2021 Jun TI - Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center. PG - 566-573 LID - 10.1007/s10903-020-01047-w [doi] AB - Our aim was to quantify successful completion of steps of the latent tuberculosis (LTBI) care cascade in a community health center (CHC) with a large foreign-born population. We conducted a retrospective cohort study of individuals with a positive test for tuberculosis (TB) infection from 2015 to 2017 at Baltimore Medical Systems (BMS). During the study period, 3,984 individuals were tested for TB. Of the 418 individuals with positive tests, 152 (36%) were referred elsewhere for care, whereas 266 (64%) were retained in care at BMS. Treatment was prescribed for 157 of the 214 (73%) diagnosed with LTBI and retained in care at BMS (125/157 [80%] four months of rifampin; 32/157 [20%] nine months of isoniazid). One hundred forty-one patients (141/157, 90%) initiated treatment, of which 119 completed therapy (119/141, 84%). Our study identified several gaps in the LTBI care cascade in a CHC. Nonetheless, a large proportion of those treated for LTBI at the CHC completed therapy. FAU - Prater, Christopher AU - Prater C AUID- ORCID: 0000-0002-4315-3766 AD - Washington University School of Medicine, Department of Medicine, Division of General Medicine, St. Louis, MO, USA. cwprater@wustl.edu. FAU - Holzman, Samuel AU - Holzman S AD - Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Disease, Baltimore, MD, USA. AD - Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. FAU - Shah, Maunank AU - Shah M AD - Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Disease, Baltimore, MD, USA. LA - eng PT - Journal Article PL - United States TA - J Immigr Minor Health JT - Journal of immigrant and minority health JID - 101256527 RN - 0 (Antitubercular Agents) RN - V83O1VOZ8L (Isoniazid) SB - IM MH - Antitubercular Agents/therapeutic use MH - Community Health Centers MH - Humans MH - Isoniazid MH - *Latent Tuberculosis/diagnosis/drug therapy/epidemiology MH - Retrospective Studies OTO - NOTNLM OT - Community health center OT - Foreign-born population OT - TB care cascade OT - Tuberculosis EDAT- 2020/07/25 06:00 MHDA- 2021/08/19 06:00 CRDT- 2020/07/25 06:00 PHST- 2020/07/25 06:00 [pubmed] PHST- 2021/08/19 06:00 [medline] PHST- 2020/07/25 06:00 [entrez] AID - 10.1007/s10903-020-01047-w [pii] AID - 10.1007/s10903-020-01047-w [doi] PST - ppublish SO - J Immigr Minor Health. 2021 Jun;23(3):566-573. doi: 10.1007/s10903-020-01047-w.